One-year increase in age at diabetes diagnosis linked to lower risk for all-cause mortality and macrovascular, microvascular disease<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Dec. 15, 2020 (HealthDay News) — Younger age at diagnosis of type 2 diabetes is associated with an increased risk for mortality and vascular disease, according to a review published online Dec. 14 in Diabetologia.<\/em><\/p>\n Natalie Nanayakkara, M.B.B.S., from Monash University in Melbourne, Australia, and colleagues examined the risk for mortality, macrovascular complications, and microvascular complications associated with age at type 2 diabetes diagnosis in a systematic review. Data were included from 26 observational studies, which included 1,325,493 individuals from 30 countries.<\/p>\n The researchers observed an inverse association between age at diabetes diagnosis and risk for all-cause mortality and macrovascular and microvascular diseases. After adjustment for current age, each one-year increase in age at diabetes diagnosis was associated with a 4, 3, and 5 percent reduction in the risks for all-cause mortality, macrovascular disease, and microvascular disease, respectively. For individual components of the composite outcome, the effects were consistent.<\/p>\n “This difference in risk between younger and older people in terms of absolute versus lifetime risks of type 2 diabetes complications should perhaps be recognized in diabetes management guidelines, with increased promotion of screening programs in older people with type 2 diabetes and a greater emphasis on preventive measures for younger people with type 2 diabetes,” Nanayakkara said in a statement.<\/p>\n Several authors disclosed financial ties to the biopharmaceutical industry.<\/p>\n